Brief: Rockwell Medical Provides Corporate And Clinical Update
22/06/2022 21:07
June 22 (Reuters) - DaVita Inc DVA.N :
* ROCKWELL MEDICAL PROVIDES CORPORATE AND CLINICAL UPDATE
* ROCKWELL - UPDATE ON RECENT CAPITAL RAISE & CLINICAL
UPDATE ON
SAFETY ENHANCEMENTS TO PLANNED PHASE 2 CLINICAL TRIAL OF FERRIC
PYROPHOSPHATE CITRATE
* ROCKWELL MEDICAL INC - FDA REQUESTED THAT CO PERFORM A
MICROBIAL
CHALLENGE STUDY FOR FERRIC PYROPHOSPHATE CITRATE
Source text for Eikon: ID:nPnlgRqZa
Further company coverage: DVA.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rockwell Medical
See all newsRockwell Medical Inc reports results for the quarter ended June 30 - Earnings Summary
Rockwell Medical Q2 sales rise 11% on new customers
Rockwell Medical Inc expected to post a loss of 23 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:30 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM